{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:23:17Z","timestamp":1793362997055,"version":"4.5.0"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bcp.2023.115574","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T19:50:26Z","timestamp":1682797826000},"page":"115574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises"],"prefix":"10.1016","volume":"212","author":[{"given":"Samaneh","family":"Zolghadri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Beygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem F.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Alijanianzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanigaimalai","family":"Pillaiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garcia-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Garcia-Canovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Munoz-Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Saboury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bcp.2023.115574_b0005","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00396-021-04905-7","article-title":"Skin bioinspired anti-ultraviolet melanin\/TiO2 nanoparticles without penetration for efficient broad-spectrum sunscreen","volume":"299","author":"Li","year":"2021","journal-title":"Colloid Polym. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/pcmr.12080","article-title":"Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells","volume":"26","author":"Bonaventure","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.bcp.2023.115574_b0015","unstructured":"J.C. Garc\u00eda-Borr\u00f3n, M.C. Olivares S\u00e1nchez."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1034\/j.1600-0749.2001.140402.x","article-title":"Keratinocyte\u2013melanocyte interactions during melanosome transfer","volume":"14","author":"Seiberg","year":"2001","journal-title":"Pigment Cell Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1751-1097.2007.00238.x","article-title":"Chemistry of Mixed Melanogenesis\u2014Pivotal Roles of Dopaquinone\u2020","volume":"84","author":"Ito","year":"2008","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.bcp.2023.115574_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174458","article-title":"Salicylic acid in ginseng root alleviates skin hyperpigmentation disorders by inhibiting melanogenesis and melanosome transport","volume":"910","author":"Liu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115574_b0035","first-page":"52","article-title":"Natural Cosmeceutical Ingredients for the Management of Hyperpigmentation in Hispanic and Latino Women","volume":"14","author":"Murphy","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cosmetics8010015","article-title":"Inhibitory Effect and Mechanism of Scutellarein on Melanogenesis","volume":"8","author":"Dai","year":"2021","journal-title":"Cosmetics"},{"key":"10.1016\/j.bcp.2023.115574_b0045","article-title":"Review on analysis of interesting whitening agents in cosmetics products","author":"Gatea","year":"2020","journal-title":"IOP Conf. Ser.: Mater. Sci. Eng., IOP Publ."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/jdv.13595","article-title":"Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe","volume":"30","author":"Desmedt","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.bcp.2023.115574_b0055","series-title":"Tanning and Whitening Agents in Cosmetics: Regulatory Aspects and Analytical Methods, Analysis of Cosmetic Products","first-page":"107","author":"Chisvert","year":"2018"},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0749.2003.00029.x","article-title":"Chemical and instrumental approaches to treat hyperpigmentation","volume":"16","author":"Briganti","year":"2003","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.bcp.2023.115574_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113744","article-title":"Recent advances in the design and discovery of synthetic tyrosinase inhibitors","volume":"224","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0070","first-page":"32","article-title":"Insight into skin lightening cosmeceuticals for women of color","volume":"6","author":"Badreshia-Bansal","year":"2007","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1346-8138.2006.00003.x","article-title":"Effects of alpha-hydroxy acids on the human skin of Japanese subjects: The rationale for chemical peeling","volume":"33","author":"Yamamoto","year":"2006","journal-title":"J. Dermatol."},{"key":"10.1016\/j.bcp.2023.115574_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0923-1811(01)00116-5","article-title":"Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes","volume":"27","author":"Yoshimura","year":"2001","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PRS.0b013e3181c83192","article-title":"Active agents in common skin care products","volume":"125","author":"Draelos","year":"2010","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bcp.2023.115574_b0090","first-page":"41","article-title":"Tyrosinase inhibitors from natural and synthetic sources as skin-lightening agents, Reviews in Agricultural","volume":"7","author":"Masum","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0095","first-page":"309","article-title":"Treatment of Periorbital Vascularity, Erythema, and Hyperpigmentation, Facial Plastic Surgery","volume":"30","author":"Samaan","year":"2022","journal-title":"Clinics"},{"issue":"9","key":"10.1016\/j.bcp.2023.115574_b0100","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.3390\/molecules27092710","article-title":"The Hypopigmentation Mechanism of Tyrosinase Inhibitory Peptides Derived from Food Proteins: An Overview","volume":"27","author":"Song","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2023.115574_b0105","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.2147\/IJN.S171532","article-title":"Development of a kojic monooleate-enriched oil-in-water nanoemulsion as a potential carrier for hyperpigmentation treatment","volume":"13","author":"Azhar","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0110","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/21691401.2020.1770271","article-title":"An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles","volume":"48","author":"Khezri","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/21691401.2020.1865993","article-title":"A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier","volume":"49","author":"Khezri","year":"2021","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/jcm10020181","article-title":"Microneedle arrays combined with nanomedicine approaches for transdermal delivery of therapeutics","volume":"10","author":"Alimardani","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0125","first-page":"57","article-title":"Evaluation of the anti-melanogenic activity of nanostructured lipid carriers containing auraptene: A natural anti-oxidant agent","volume":"9","author":"Daneshmand","year":"2022","journal-title":"Nanomed. J."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0130","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/mec.15024","article-title":"Changes in melanocyte RNA and DNA methylation favour pheomelanin synthesis and may avoid systemic oxidative stress after dietary cysteine supplementation in birds","volume":"28","author":"Rodr\u00edguez-Mart\u00ednez","year":"2019","journal-title":"Mol. Ecol."},{"key":"10.1016\/j.bcp.2023.115574_b0135","doi-asserted-by":"crossref","first-page":"lb62-lb62","DOI":"10.1096\/fasebj.31.1_supplement.lb62","article-title":"Identification of misregulated histone post translational modifications in melanoma","volume":"31","author":"Davis","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2023.115574_b0140","first-page":"1","article-title":"MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis","author":"Shin","year":"2021","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b0145","doi-asserted-by":"crossref","first-page":"e1005555","DOI":"10.1371\/journal.pgen.1005555","article-title":"Chromatin-remodelling complex NURF is essential for differentiation of adult melanocyte stem cells","volume":"11","author":"Koludrovic","year":"2015","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0150","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.18632\/aging.202320","article-title":"Identification of the ceRNA networks in \u03b1-MSH-induced melanogenesis of melanocytes","volume":"13","author":"Jiang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0155","first-page":"1","article-title":"Melasma and post inflammatory hyperpigmentation: management update and expert opinion","volume":"21","author":"Sofen","year":"2016","journal-title":"Skin Therapy Lett."},{"key":"10.1016\/j.bcp.2023.115574_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.577284","article-title":"7, 3\u2032, 4\u2032-Trihydroxyisoflavone, a Metabolite of the Soy Isoflavone Daidzein, Suppresses \u03b1-Melanocyte-Stimulating Hormone-Induced Melanogenesis by Targeting Melanocortin 1 Receptor","volume":"7","author":"Kim","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b0165","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1039\/c9pp00059c","article-title":"The inhibitory effect of silk sericin against ultraviolet-induced melanogenesis and its potential use in cosmeceutics as an anti-hyperpigmentation compound","volume":"18","author":"Kumar","year":"2019","journal-title":"Photochem. Photobiol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2016.1256882","article-title":"Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors","volume":"32","author":"Pillaiyar","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3892\/ijmm.2017.3061","article-title":"Soyasaponin Ag inhibits \u03b1-MSH-induced melanogenesis in B16F10 melanoma cells via the downregulation of TRP-2","volume":"40","author":"Yang","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2023.115574_b0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2014.07.003","article-title":"Cyclic AMP (cAMP) signaling in melanocytes and melanoma","volume":"563","author":"Rodr\u00edguez","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2023.115574_b0185","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3389\/fphar.2020.602889","article-title":"FGIN-1-27 Inhibits Melanogenesis by Regulating Protein Kinase A\/cAMP-Responsive Element-Binding, Protein Kinase C-\u03b2, and Mitogen-Activated Protein Kinase Pathways","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0190","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/vco.12118","article-title":"Analysis of microRNA-203 function in CREB\/MITF\/RAB27a pathway: comparison between canine and human melanoma cells","volume":"14","author":"Noguchi","year":"2016","journal-title":"Vet. Comp. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drudis.2016.09.016","article-title":"Downregulation of melanogenesis: drug discovery and therapeutic options","volume":"22","author":"Pillaiyar","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0200","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/ijms17071144","article-title":"Signaling pathways in melanogenesis","volume":"17","author":"D\u2019Mello","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.bcp.2023.115574_b0205","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1016\/j.bmc.2016.08.023","article-title":"ArgTX-636, a polyamine isolated from spider venom: A novel class of melanogenesis inhibitors","volume":"24","author":"Verdoni","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0210","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/ijms17040546","article-title":"A Novel Role of Serotonin Receptor 2B Agonist as an Anti-Melanogenesis Agent","volume":"17","author":"Oh","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.bcp.2023.115574_b0215","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1111\/bph.13134","article-title":"cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide","volume":"172","author":"Shin","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/cosmetics6030051","article-title":"Calebin-A, a curcuminoid analog inhibits \u03b1-MSH-induced melanogenesis in B16F10 mouse melanoma cells","volume":"6","author":"Goenka","year":"2019","journal-title":"Cosmetics"},{"issue":"24","key":"10.1016\/j.bcp.2023.115574_b0225","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1016\/j.febslet.2013.10.027","article-title":"ARP101 inhibits \u03b1-MSH-stimulated melanogenesis by regulation of autophagy in melanocytes","volume":"587","author":"Kim","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2023.115574_b0230","doi-asserted-by":"crossref","unstructured":"X. Li, H.-W. Yang, Y. Jiang, J.-Y. Oh, Y.-J. Jeon, B. Ryu, Ishophloroglucin A Isolated from Ishige okamurae Suppresses Melanogenesis Induced by \u03b1-MSH: In Vitro and In Vivo, Marine drugs 18(9) (2020) 470.","DOI":"10.3390\/md18090470"},{"key":"10.1016\/j.bcp.2023.115574_b0235","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/842569","article-title":"[6]-Shogaol inhibits \u03b1-MSH-induced melanogenesis through the acceleration of ERK and PI3K\/Akt-mediated MITF degradation","volume":"2014","author":"Huang","year":"2014","journal-title":"Biomed Res Int"},{"issue":"11","key":"10.1016\/j.bcp.2023.115574_b0240","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/ijms17111798","article-title":"Effects of Ganodermanondiol, a New Melanogenesis Inhibitor from the Medicinal Mushroom Ganoderma lucidum","volume":"17","author":"Kim","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0245","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0030-1250285","article-title":"Hypopigmenting activity of bisabolangelone isolated from Angelica koreana Maxim. in \u03b1-melanocyte stimulating hormone-activated B16 or melan-a cells","volume":"77","author":"Roh","year":"2011","journal-title":"Planta Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4196\/kjpp.2018.22.1.53","article-title":"Ethyl linoleate inhibits \u03b1-MSH-induced melanogenesis through Akt\/GSK3\u03b2\/\u03b2-catenin signal pathway","volume":"22","author":"Ko","year":"2018","journal-title":"Kor. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0255","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/jid.2013.341","article-title":"Downregulation of melanocyte-specific facultative melanogenesis by 4-hydroxy-3-methoxycinnamaldehyde acting as a cAMP antagonist","volume":"134","author":"Roh","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0260","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1248\/bpb.b17-01045","article-title":"Mansonone E from Mansonia gagei inhibited \u03b1-MSH-induced melanogenesis in B16 cells by inhibiting CREB expression and phosphorylation in the PI3K\/Akt pathway","volume":"41","author":"Nishina","year":"2018","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/ijms18020320","article-title":"Plumbagin Suppresses \u03b1-MSH-Induced Melanogenesis in B16F10 Mouse Melanoma Cells by Inhibiting Tyrosinase Activity","volume":"18","author":"Oh","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"s1","key":"10.1016\/j.bcp.2023.115574_b0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.12051","article-title":"4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation","volume":"27","author":"Kolbe","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0275","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1346-8138.2010.00787.x","article-title":"Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial, The","volume":"37","author":"Huh","year":"2010","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0280","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2133.2007.07814.x","article-title":"Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial","volume":"156","author":"Khemis","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115574_b0285","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.3390\/ijms22083861","article-title":"Protocatechuic Aldehyde Inhibits \u03b1-MSH-Induced Melanogenesis in B16F10 Melanoma Cells via PKA\/CREB-Associated MITF Downregulation","volume":"22","author":"Ko","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0290","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10695-016-0306-3","article-title":"Zebrafish phosvitin-derived peptide Pt5 inhibits melanogenesis via cAMP pathway","volume":"43","author":"Liu","year":"2017","journal-title":"Fish Physiol. Biochem."},{"key":"10.1016\/j.bcp.2023.115574_b0295","doi-asserted-by":"crossref","unstructured":"S.-Y. Chung, Y.-K. Seo, J.-M. Park, M.-J. Seo, J.-K. Park, J.-W. Kim, C.-S. Park, Fermented rice bran downregulates MITF expression and leads to inhibition of \u03b1-MSH-induced melanogenesis in B16F1 melanoma, Bioscience, biotechnology, and biochemistry (2009) 0907071540-0907071540.","DOI":"10.1271\/bbb.80766"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0300","first-page":"1","article-title":"Soft corals collected from Jeju Island inhibits the \u03b1-MSH-induced melanogenesis in B16F10 cells through activation of ERK","volume":"21","author":"Sanjeewa","year":"2018","journal-title":"Fisheries and Aquatic Sciences"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/cosmetics6010009","article-title":"Inonotus obliquus Extract as An Inhibitor of \u03b1-MSH-Induced Melanogenesis in B16F10 Mouse Melanoma Cells","volume":"6","author":"Lee","year":"2019","journal-title":"Cosmetics"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0310","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/ijms20030536","article-title":"Leathesia difformis extract inhibits \u03b1-MSH-induced melanogenesis in B16F10 cells via down-regulation of CREB signaling pathway","volume":"20","author":"Seo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2023.115574_b0315","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/md18090473","article-title":"Jeju Magma-Seawater Inhibits \u03b1-MSH-Induced Melanogenesis via CaMKK\u03b2-AMPK Signaling Pathways in B16F10 Melanoma Cells","volume":"18","author":"Song","year":"2020","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41240-019-0126-3","article-title":"A mixture of seaweed extracts and glycosaminoglycans from sea squirts inhibits \u03b1-MSH-induced melanogenesis in B16F10 melanoma cells","volume":"22","author":"Wang","year":"2019","journal-title":"Fisheries and Aquatic Sciences"},{"key":"10.1016\/j.bcp.2023.115574_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.783730","article-title":"The Inhibitory Effect of Curcumin Derivative J147 on Melanogenesis and Melanosome Transport by Facilitating ERK-Mediated MITF Degradation","volume":"12","author":"Lv","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bcp.2023.115574_b0330","doi-asserted-by":"crossref","DOI":"10.1111\/exd.13056","article-title":"Mevastatin suppresses melanogenesis by lowering the levels of cyclic adenosine monophosphate and cholesterol","volume":"25","author":"Lee","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bcp.2023.115574_b0335","doi-asserted-by":"crossref","unstructured":"K.w. Lee, H.W. Ryu, S.-s. Oh, S. Park, H. Madhi, J. Yoo, K.-H. Park, K.D. Kim, Depigmentation of \u03b1-melanocyte-stimulating hormone-treated melanoma cells by \u03b2-mangostin is mediated by selective autophagy, Experimental Dermatol. 26(7) (2017) 585-591.","DOI":"10.1111\/exd.13233"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2013.11.048","article-title":"Autophagy mediates anti-melanogenic activity of 3\u2032-ODI in B16F1 melanoma cells","volume":"442","author":"Kim","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0345","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.3390\/ijms15058293","article-title":"Inhibitors of intracellular signaling pathways that lead to stimulated epidermal pigmentation: perspective of anti-pigmenting agents","volume":"15","author":"Imokawa","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0350","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.phymed.2014.03.003","article-title":"Anti-melanogenic effects of \u03b4-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells","volume":"21","author":"Ng","year":"2014","journal-title":"Phytomed. : Int. J. Phytother. Phytopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0355","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/php.12400","article-title":"Nobiletin, a Polymethoxy Flavonoid, Reduced Endothelin-1 Plus SCF-Induced Pigmentation in Human Melanocytes","volume":"91","author":"Kim","year":"2015","journal-title":"Photochem Photobiol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0360","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jep.2013.10.054","article-title":"Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways","volume":"151","author":"Ko","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115574_b0365","doi-asserted-by":"crossref","first-page":"18384","DOI":"10.3390\/ijms160818384","article-title":"Hesperidin, A Popular Antioxidant Inhibits Melanogenesis via Erk1\/2 Mediated MITF Degradation","volume":"16","author":"Lee","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0370","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/exd.12943","article-title":"Dopamine D4 receptor antagonist inhibits melanogenesis through transcriptional downregulation of MITF via ERK signalling","volume":"25","author":"Jung","year":"2016","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/tox.22023","article-title":"Hinokitiol induces autophagy in murine breast and colorectal cancer cells","volume":"31","author":"Wang","year":"2016","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bcp.2023.115574_b0380","doi-asserted-by":"crossref","unstructured":"Y.-T. Tsao, Y.-F. Huang, C.-Y. Kuo, Y.-C. Lin, W.-C. Chiang, W.-K. Wang, C.-W. Hsu, C.-H. Lee, Hinokitiol Inhibits Melanogenesis via AKT\/mTOR Signaling in B16F10 Mouse Melanoma Cells, International journal of molecular sciences 17(2) (2016) 248-248.","DOI":"10.3390\/ijms17020248"},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0385","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7164\/antibiotics.47.208","article-title":"Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite","volume":"47","author":"Fujita","year":"1994","journal-title":"J. Antibiot."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0390","doi-asserted-by":"crossref","first-page":"e33021","DOI":"10.1371\/journal.pone.0033021","article-title":"Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt\/\u03b2-catenin signaling pathway","volume":"7","author":"Bellei","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b0395","doi-asserted-by":"crossref","first-page":"20443","DOI":"10.3390\/ijms141020443","article-title":"Inhibition of melanogenesis by gallic acid: Possible involvement of the PI3K\/Akt, MEK\/ERK and Wnt\/\u03b2-catenin signaling pathways in B16F10 cells","volume":"14","author":"Su","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0400","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.gendis.2020.06.003","article-title":"SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt\/\u03b2-catenin signaling","volume":"8","author":"Zou","year":"2021","journal-title":"Genes & Diseases"},{"issue":"15","key":"10.1016\/j.bcp.2023.115574_b0405","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1016\/j.bmcl.2013.05.094","article-title":"The inhibitory effect of a synthetic compound, (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione (MHY498), on nitric oxide-induced melanogenesis","volume":"23","author":"Kim","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0410","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/j.jdermsci.2012.11.572","article-title":"Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MiTF degradation","volume":"69","author":"Lim","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2023.115574_b0415","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/exd.12531","article-title":"Role of epidermal \u03b3\u03b4 T-cell-derived interleukin 13 in the skin-whitening effect of Ginsenoside F1","volume":"23","author":"Han","year":"2014","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0420","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.bmcl.2014.01.040","article-title":"MHY884, a newly synthesized tyrosinase inhibitor, suppresses UVB-induced activation of NF-\u03baB signaling pathway through the downregulation of oxidative stress","volume":"24","author":"Choi","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0425","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.stem.2015.05.009","article-title":"Epigenetic Control of Stem Cell Potential during Homeostasis","volume":"16","author":"Beerman","year":"2015","journal-title":"Aging, and Disease, Cell Stem Cell"},{"key":"10.1016\/j.bcp.2023.115574_b0430","first-page":"9068314","article-title":"DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo","author":"Campuzano-Garc\u00eda","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2023.115574_b0435","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9068314","article-title":"DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo","author":"Campuzano-Garc\u00eda","year":"2019","journal-title":"Biomed Res. Int."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0440","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1755-148X.2008.00480.x","article-title":"Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage","volume":"21","author":"Yokoyama","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"issue":"12","key":"10.1016\/j.bcp.2023.115574_b0445","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1158\/1535-7163.MCT-18-0511","article-title":"Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300\/CBP","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0450","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mnfr.201500822","article-title":"Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma","volume":"60","author":"Liu-Smith","year":"2016","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0455","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10571-017-0547-4","article-title":"Plant and animal microRNAs (miRNAs) and their potential for inter-kingdom communication","volume":"38","author":"Zhao","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0460","doi-asserted-by":"crossref","first-page":"865","DOI":"10.17219\/acem\/62915","article-title":"MicroRNA in cardiovascular biology and disease","volume":"26","author":"Wojciechowska","year":"2017","journal-title":"Adv. Clin. Experimental Med.: Off. Organ Wroclaw Medical Univ."},{"key":"10.1016\/j.bcp.2023.115574_b0465","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopha.2018.09.090","article-title":"MicroRNAs as Biological Regulators in Skin Disorders","volume":"108","author":"Singhvi","year":"2018","journal-title":"Biomed. Pharmacother.= Biomed. Pharmacotherapie"},{"issue":"11","key":"10.1016\/j.bcp.2023.115574_b0470","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.3390\/ijms22116104","article-title":"microRNAs in the Regulation of Melanogenesis","volume":"22","author":"Hushcha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0475","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1684\/ejd.2017.3024","article-title":"MicroRNA in skin diseases","volume":"27","author":"Ruksha","year":"2017","journal-title":"Eur. J. Dermatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0480","first-page":"742","article-title":"MicroRNA-155 is Dysregulated in the Skin of Patients with Vitiligo and Inhibits Melanogenesis-associated Genes in Melanocytes and Keratinocytes","volume":"96","author":"\u0160ahmatova","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0485","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/00071668.2019.1709619","article-title":"Identification of key microRNAs affecting melanogenesis of breast muscle in Muchuan black-boned chickens by RNA sequencing","volume":"61","author":"Yu","year":"2020","journal-title":"Br. Poult. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-58911-w","article-title":"MicroRNA-141-3p and microRNA-200a-3p regulate \u03b1-melanocyte stimulating hormone-stimulated melanogenesis by directly targeting microphthalmia-associated transcription factor","volume":"10","author":"Itoh","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0495","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/pcmr.12605","article-title":"Arginase-2, a miR-1299 target, enhances pigmentation in melasma by reducing melanosome degradation via senescence-induced autophagy inhibition","volume":"30","author":"Kim","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"issue":"8","key":"10.1016\/j.bcp.2023.115574_b0500","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/tox.22421","article-title":"Regulation of miR-21 expression in human melanoma via UV-ray-induced melanin pigmentation","volume":"32","author":"Lin","year":"2017","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0505","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI75852","article-title":"Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways","volume":"125","author":"Gomez","year":"2015","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0510","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0515","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jid.2019.04.029","article-title":"The long noncoding RNA UCA1 negatively regulates melanogenesis in melanocytes","volume":"140","author":"Pei","year":"2020","journal-title":"J, Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0520","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40259-017-0243-4","article-title":"Advances in the application and impact of MicroRNAs as therapies for skin disease","volume":"31","author":"Lawrence","year":"2017","journal-title":"BioDrugs"},{"issue":"21","key":"10.1016\/j.bcp.2023.115574_b0525","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2174\/1381612825666190709210703","article-title":"Nanomedicines to Treat Skin Pathologies with Natural Molecules","volume":"25","author":"Esposito","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0530","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14756360601114536","article-title":"The inhibitory effect of some new synthesized xanthates on mushroom tyrosinase activities","volume":"22","author":"Alijanianzadeh","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0535","doi-asserted-by":"crossref","first-page":"183","DOI":"10.18388\/abp.2007_3285","article-title":"The role of alkyl chain length in the inhibitory effect n-alkyl xanthates on mushroom tyrosinase activities","volume":"54","author":"Saboury","year":"2007","journal-title":"Acta Biochim. Pol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0540","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/07391102.2012.682210","article-title":"Inhibition of mushroom tyrosinase by a newly synthesized ligand: inhibition kinetics and computational simulations","volume":"30","author":"Alijanianzadeh","year":"2012","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0545","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1080\/14756360802632658","article-title":"Dual effects of aliphatic carboxylic acids on cresolase and catecholase reactions of mushroom tyrosinase","volume":"24","author":"Gheibi","year":"2009","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0550","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/14756360600810787","article-title":"The inhibitory effect of benzenethiol on the cresolase and catecholase activities of mushroom tyrosinase","volume":"21","author":"Saboury","year":"2006","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0555","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14756360500179903","article-title":"The inhibition effect of some n-alkyl dithiocarbamates on mushroom tyrosinase","volume":"20","author":"Gheibi","year":"2005","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0560","doi-asserted-by":"crossref","first-page":"277","DOI":"10.18388\/abp.2010_2406","article-title":"Evaluation of p-phenylene-bis and phenyl dithiocarbamate sodium salts as inhibitors of mushroom tyrosinase","volume":"57","author":"Amin","year":"2010","journal-title":"Acta Biochim. Pol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0565","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/14756360903179351","article-title":"Potent inhibitory effects of benzyl and p-xylidine-bis dithiocarbamate sodium salts on activities of mushroom tyrosinase","volume":"25","author":"Amin","year":"2010","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0570","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijbiomac.2012.01.030","article-title":"The inhibitory effect of ethylenediamine on mushroom tyrosinase","volume":"50","author":"Alijanianzadeh","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"issue":"15","key":"10.1016\/j.bcp.2023.115574_b0575","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1016\/j.bmcl.2009.06.018","article-title":"Synthesis and evaluation of 5-benzylidene(thio)barbiturate-beta-D-glycosides as mushroom tyrosinase inhibitors","volume":"19","author":"Yan","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bcp.2023.115574_b0580","doi-asserted-by":"crossref","first-page":"28534","DOI":"10.3390\/ijms161226114","article-title":"Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors","volume":"16","author":"Choi","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115574_b0585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.compbiolchem.2018.03.007","article-title":"In silico modelling of azole derivatives with tyrosinase inhibition ability: Application of the models for activity prediction of new compounds","volume":"74","author":"De","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115574_b0590","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bioorg.2018.04.026","article-title":"Synthesis of aryl pyrazole via Suzuki coupling reaction, in vitro mushroom tyrosinase enzyme inhibition assay and in silico comparative molecular docking analysis with Kojic acid","volume":"79","author":"Channar","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b0595","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.bmc.2012.12.053","article-title":"Synthesis of new heterocyclic hybrids based on pyrazole and thiazolidinone scaffolds as potent inhibitors of tyrosinase","volume":"21","author":"Gawande","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0600","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.bmc.2012.12.054","article-title":"Design and synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles as new tyrosinase inhibitors","volume":"21","author":"Zhou","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2023.115574_b0605","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1016\/j.bmc.2010.06.046","article-title":"Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents","volume":"18","author":"Bandgar","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2023.115574_b0610","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11030-005-1299-5","article-title":"A facile and improved synthesis of sildenafil (Viagra) analogs through solid support microwave irradiation possessing tyrosinase inhibitory potential, their conformational analysis and molecular dynamics simulation studies","volume":"9","author":"Khan","year":"2005","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0615","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/14756366.2016.1238362","article-title":"Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity","volume":"32","author":"Mojzych","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"23","key":"10.1016\/j.bcp.2023.115574_b0620","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1016\/j.bmc.2014.10.009","article-title":"Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity","volume":"22","author":"Mojzych","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0625","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cbdd.13352","article-title":"Novel 1,3-oxazine-tetrazole hybrids as mushroom tyrosinase inhibitors and free radical scavengers: Synthesis, kinetic mechanism, and molecular docking studies","volume":"93","author":"Qamar","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"issue":"9","key":"10.1016\/j.bcp.2023.115574_b0630","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2174\/1871520618666180417163226","article-title":"Ultrasound Promoted Green Synthesis, Docking Study of Indole Spliced Thiadiazole, \u03b1-amino Phosphonates as Anticancer Agents and Antityrosinase Agents","volume":"18","author":"Nikalje","year":"2018","journal-title":"Anticancer Agents Med Chem."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0635","doi-asserted-by":"crossref","first-page":"e1800120","DOI":"10.1002\/cbdv.201800120","article-title":"Synthesis of New Benzimidazole-1,2,3-triazole Hybrids as Tyrosinase Inhibitors","volume":"15","author":"Mahdavi","year":"2018","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bcp.2023.115574_b0640","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bioorg.2018.06.005","article-title":"Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents","volume":"80","author":"Chekir","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.bcp.2023.115574_b0645","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.bmc.2018.05.047","article-title":"The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-\u03b2-phenyl-\u03b1, \u03b2-unsaturated carbonyl scaffold","volume":"26","author":"Kim","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0650","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.bmc.2013.01.014","article-title":"Synthesis of novel azo compounds containing 5(4H)-oxazolone ring as potent tyrosinase inhibitors","volume":"21","author":"Hamidian","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"Pt B","key":"10.1016\/j.bcp.2023.115574_b0655","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.ijbiomac.2017.10.066","article-title":"Determining mushroom tyrosinase inhibition by imidazolium ionic liquids: A spectroscopic and molecular docking study","volume":"107","author":"Heitz","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0660","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030690","article-title":"Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase","volume":"19","author":"Mann","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115574_b0665","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijbiomac.2017.11.147","article-title":"Evaluation of thiazolidinone derivatives as a new class of mushroom tyrosinase inhibitors","volume":"108","author":"Rezaei","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b0670","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s12272-013-0184-5","article-title":"Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor","volume":"36","author":"Kim","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bcp.2023.115574_b0675","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejmech.2012.01.019","article-title":"Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors","volume":"49","author":"Ha","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0680","first-page":"542","article-title":"Characterization of a novel tyrosinase inhibitor, (2RS,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid (MHY384)","volume":"1820","author":"Han","year":"2012","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0685","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biochi.2011.09.002","article-title":"Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors","volume":"94","author":"Ha","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2023.115574_b0690","doi-asserted-by":"crossref","unstructured":"H.J. Jung, M.J. Lee, Y.J. Park, S.G. Noh, A.K. Lee, K.M. Moon, E.K. Lee, E.J. Bang, Y.J. Park, S.J. Kim, J. Yang, S. Ullah, P. Chun, Y.S. Jung, H.R. Moon, H.Y. Chung, A novel synthetic compound, (Z)-5-(3-hydroxy-4-methoxybenzylidene)-2-iminothiazolidin-4-one (MHY773) inhibits mushroom tyrosinase, Bioscience, biotechnology, and biochemistry (2018) 1-9.","DOI":"10.1080\/09168451.2018.1445518"},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0695","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.1995.tb00669.x","article-title":"Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase","volume":"8","author":"Kahn","year":"1995","journal-title":"Pigment Cell Res"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0700","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bmcl.2016.12.027","article-title":"Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase","volume":"27","author":"Xie","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0705","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jbiosc.2016.06.002","article-title":"Novel synthetic kojic acid-methimazole derivatives inhibit mushroom tyrosinase and melanogenesis","volume":"122","author":"Chen","year":"2016","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.bcp.2023.115574_b0710","doi-asserted-by":"crossref","unstructured":"M.d.M. Garcia-Molina, J. Berna, J.L. Mu\u00f1oz-Mu\u00f1oz, P.A. Garc\u00eda-Ruiz, M.G. Moreno, J.R. Martinez, F. Garcia-Canovas, Action of tyrosinase on hydroquinone in the presence of catalytic amounts of o-diphenol. A kinetic study, Reaction Kinetics, Mech. Catal. 112(2) (2014) 305-320.","DOI":"10.1007\/s11144-014-0723-1"},{"issue":"13","key":"10.1016\/j.bcp.2023.115574_b0715","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/j.bmc.2014.04.048","article-title":"Tyrosinase-catalyzed hydroxylation of hydroquinone, a depigmenting agent, to hydroxyhydroquinone: A kinetic study","volume":"22","author":"del Mar Garc\u00eda-Molina","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0720","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbapap.2009.04.002","article-title":"Generation of hydrogen peroxide in the melanin biosynthesis pathway","volume":"1794","author":"Munoz-Munoz","year":"2009","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0725","first-page":"1","volume":"1247","author":"S\u00e1nchez-Ferrer","year":"1995","journal-title":"Tyrosinase: a comprehensive review of its mechanism, Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular Enzymology"},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b0730","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/iub.1432","article-title":"Kinetic characterization of substrate-analogous inhibitors of tyrosinase","volume":"67","author":"Ortiz-Ruiz","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bcp.2023.115574_b0735","doi-asserted-by":"crossref","unstructured":"C.V. Ortiz-Ruiz, M.d.M. Garcia-Molina, J.T. Serrano, V. Tomas-Martinez, F. Garcia-Canovas, Discrimination between alternative substrates and inhibitors of tyrosinase, J. Agricult. Food Chem. 63(8) (2015) 2162-2171.","DOI":"10.1021\/jf5051816"},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0740","first-page":"5587","article-title":"Two Different Behaviours of mushroom tyrosinase on the impact of different concentrations of thiophenol in acidic medium","volume":"19","author":"Zolghadri","year":"2007","journal-title":"Asian J. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0745","first-page":"127","article-title":"Inhibition Properties and Thermodynamic Changes of Binding of p-perazine-bis and p-peridine Dithiocarbamate Sodium Salts to Mushroom Tyrosinase","volume":"38","author":"Amin","year":"2019","journal-title":"Iran. J. Chem. Chem. Eng. (IJCCE)"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0750","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2010_2406","article-title":"Evaluation of p-phenylene-bis and phenyl dithiocarbamate sodium salts as inhibitors of mushroom tyrosinase","volume":"57","author":"Amin","year":"2010","journal-title":"Acta Biochim. Pol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0755","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14756366.2018.1545767","article-title":"A comprehensive review on tyrosinase inhibitors","volume":"34","author":"Zolghadri","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bcp.2023.115574_b0760","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8872920","article-title":"Diarylalkanoids as potent tyrosinase inhibitors from the stems of Semecarpus caudata","volume":"2021","author":"Dang","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0765","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13596-020-00455-5","article-title":"Tyrosinase inhibitors of Galla Rhois and its derivative components","volume":"21","author":"Parvez","year":"2021","journal-title":"Advances in Traditional Medicine"},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0770","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/plants10050969","article-title":"Citral-Containing Essential Oils as Potential Tyrosinase Inhibitors: A Bio-Guided Fractionation Approach","volume":"10","author":"Capetti","year":"2021","journal-title":"Plants"},{"key":"10.1016\/j.bcp.2023.115574_b0775","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2020.00081","article-title":"Inhibition of tyrosinase by mercury chloride: Spectroscopic and docking studies","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-021-00780-z","article-title":"Design, synthesis, and biological evaluation of symmetrical azine derivatives as novel tyrosinase inhibitors","volume":"15","author":"Karimian","year":"2021","journal-title":"BMC chemistry"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0785","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/BJ20080892","article-title":"Phenolic substrates and suicide inactivation of tyrosinase: kinetics and mechanism","volume":"416","author":"Mu\u00f1oz-Mu\u00f1oz","year":"2008","journal-title":"Biochem. J"},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0790","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/iub.348","article-title":"Suicide inactivation of the diphenolase and monophenolase activities of tyrosinase","volume":"62","author":"Mu\u00f1oz-Mu\u00f1oz","year":"2010","journal-title":"IUBMB Life"},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0795","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.bbapap.2010.02.015","article-title":"Tyrosinase inactivation in its action on dopa","volume":"1804","author":"Munoz-Munoz","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0800","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbapap.2008.10.002","article-title":"Stereospecific inactivation of tyrosinase by L-and D-ascorbic acid","volume":"1794","author":"Munoz-Munoz","year":"2009","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"9","key":"10.1016\/j.bcp.2023.115574_b0805","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1271\/bbb.90965","article-title":"Melanogenesis inhibition due to NADH","volume":"74","author":"Garcia-Molina","year":"2010","journal-title":"Biosci. Biotech. Bioch."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0810","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3109\/14756366.2010.548811","article-title":"Suicide inactivation of tyrosinase in its action on tetrahydropterines","volume":"26","author":"Mu\u00f1oz-Mu\u00f1oz","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0815","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/jf1035433","article-title":"Tetrahydrofolic acid is a potent suicide substrate of mushroom tyrosinase","volume":"59","author":"Garc\u00eda-Molina","year":"2011","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0820","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2620597","article-title":"A kinetic study of the suicide inactivation of an enzyme measured through coupling reactions. Application to the suicide inactivation of tyrosinase","volume":"262","author":"Escribano","year":"1989","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0825","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbapap.2012.02.001","article-title":"Kinetic characterisation of o-aminophenols and aromatic o-diamines as suicide substrates of tyrosinase","volume":"1824","author":"Mu\u00f1oz-Mu\u00f1oz","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"key":"10.1016\/j.bcp.2023.115574_b0830","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcatb.2011.11.001","article-title":"Unravelling the suicide inactivation of tyrosinase: A discrimination between mechanisms","volume":"75","author":"Mu\u00f1oz-Mu\u00f1oz","year":"2012","journal-title":"J. Mol. Catal. B Enzym."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0835","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1042\/bj2930859","article-title":"Oxygen Michaelis constants for tyrosinase","volume":"293","author":"Rodriguez-Lopez","year":"1993","journal-title":"Biochem. J"},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0840","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1357-2725(01)00133-9","article-title":"Michaelis constants of mushroom tyrosinase with respect to oxygen in the presence of monophenols and diphenols","volume":"34","author":"Fenoll","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115574_b0845","doi-asserted-by":"crossref","unstructured":"J.L. Mu\u00f1oz-Mu\u00f1oz, M.d.M. Garc\u00eda-Molina, F. Garc\u00eda-Molina, R. Varon, P.A. Garc\u00eda-Ruiz, J.N. Rodr\u00edguez-L\u00f3pez, F. Garc\u00eda-C\u00e1novas, Indirect inactivation of tyrosinase in its action on 4-tert-butylphenol, Journal of Enzyme Inhibition and Medicinal Chemistry 29(3) (2014) 344-352.","DOI":"10.3109\/14756366.2013.782298"},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0850","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2011_2214","article-title":"Indirect inactivation of tyrosinase in its action on tyrosine","volume":"58","author":"Mu\u00f1oz-Mu\u00f1oz","year":"2011","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bcp.2023.115574_b0855","article-title":"Considerations about the kinetic mechanism of tyrosinase in its action on monophenols: A review","volume":"518","author":"Garc\u00eda-Molina","year":"2022","journal-title":"Mol. Catal."},{"issue":"5","key":"10.1016\/j.bcp.2023.115574_b0860","doi-asserted-by":"crossref","first-page":"e0177330","DOI":"10.1371\/journal.pone.0177330","article-title":"Action of tyrosinase on alpha and beta-arbutin: A kinetic study","volume":"12","author":"Garcia-Jimenez","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0865","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1248\/bpb.b13-00119","article-title":"Study of umbelliferone hydroxylation to esculetin catalyzed by polyphenol oxidase","volume":"36","author":"Munoz-Munoz","year":"2013","journal-title":"Biol. Pharm. Bull."},{"issue":"13","key":"10.1016\/j.bcp.2023.115574_b0870","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1016\/j.bmc.2015.04.016","article-title":"Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates","volume":"23","author":"Ortiz-Ruiz","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"31","key":"10.1016\/j.bcp.2023.115574_b0875","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1021\/acs.jafc.5b02523","article-title":"Tyrosinase-catalyzed hydroxylation of 4-hexylresorcinol, an antibrowning and depigmenting agent: a kinetic study","volume":"63","author":"Ortiz-Ruiz","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2023.115574_b0880","doi-asserted-by":"crossref","unstructured":"C.V. Ortiz\u2010Ruiz, M. Ballesta de los Santos, J. Berna, J. Fenoll, P.A. Garcia\u2010Ruiz, J. Tudela, F. Garcia\u2010Canovas, Kinetic characterization of oxyresveratrol as a tyrosinase substrate, Iubmb Life 67(11) (2015) 828-836.","DOI":"10.1002\/iub.1439"},{"issue":"8","key":"10.1016\/j.bcp.2023.115574_b0885","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/iub.1528","article-title":"4-n-butylresorcinol, a depigmenting agent used in cosmetics, reacts with tyrosinase","volume":"68","author":"Garcia-Jimenez","year":"2016","journal-title":"IUBMB Life"},{"issue":"16","key":"10.1016\/j.bcp.2023.115574_b0890","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/acs.jafc.7b00446","article-title":"Spectrophotometric characterization of the action of tyrosinase on p-coumaric and caffeic acids: characteristics of o-caffeoquinone","volume":"65","author":"Garcia-Jimenez","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2023.115574_b0895","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijbiomac.2018.07.173","article-title":"Catalysis and inhibition of tyrosinase in the presence of cinnamic acid and some of its derivatives","volume":"119","author":"Garcia-Jimenez","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115574_b0900","doi-asserted-by":"crossref","first-page":"e0187845","DOI":"10.1371\/journal.pone.0187845","article-title":"Structural and kinetic considerations on the catalysis of deoxyarbutin by tyrosinase","volume":"12","author":"Garcia-Jimenez","year":"2017","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bcp.2023.115574_b0905","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1016\/j.bmc.2016.07.048","article-title":"Characterization of the action of tyrosinase on resorcinols","volume":"24","author":"Garcia-Jimenez","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0910","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cosmetics9030064","article-title":"Review on the Use of Kojic Acid—A Skin-Lightening Ingredient","volume":"9","author":"Phasha","year":"2022","journal-title":"Cosmetics"},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0915","article-title":"Formulation of triple cream for treatment of melasma","volume":"15","author":"Malakooti","year":"2020","journal-title":"Jundishapur J. Nat. Pharm. Products"},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b0920","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1111\/jocd.14746","article-title":"Hyperpigmentation: Looking beyond hydroquinone","volume":"21","author":"Charoo","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0925","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/app12063177","article-title":"Spreading of Dangerous Skin-Lightening Products as a Result of Colourism: A Review","volume":"12","author":"Juliano","year":"2022","journal-title":"Appl. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0930","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/ijd.15878","article-title":"Exogenous ochronosis associated with hydroquinone: a systematic review","volume":"61","author":"Ishack","year":"2022","journal-title":"Int. J. Dermatol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115574_b0935","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18115650","article-title":"Trends in Use of Prescription Skin Lightening Creams","volume":"18","author":"Saade","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b0940","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/app12020775","article-title":"Skin Depigmenting Agents in Anti-Aging Cosmetics: A Medicinal Perspective on Emerging Ingredients","volume":"12","author":"Resende","year":"2022","journal-title":"Appl. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2023.115574_b0945","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1111\/jocd.13771","article-title":"An effective hydroquinone alternative for topical skin lightening","volume":"19","author":"Draelos","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b0950","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1111\/jocd.15048","article-title":"Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%\/ascorbic acid 3% combination cream in the treatment of epidermal melasma","volume":"21","author":"Sepaskhah","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115574_b0955","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ics.12626","article-title":"Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study","volume":"42","author":"Philipp-Dormston","year":"2020","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.bcp.2023.115574_b0960","doi-asserted-by":"crossref","DOI":"10.1007\/s00403-022-02514-0","article-title":"Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance","author":"Wu","year":"2022","journal-title":"Arch. Dermatol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0965","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jocd.12769","article-title":"Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study","volume":"18","author":"Nofal","year":"2019","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b0970","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/ced.14959","article-title":"Topical Cyperus rotundus essential oil for treatment of axillary hyperpigmentation: a randomized, double-blind, active- and placebo-controlled study","volume":"47","author":"Mohammed","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0975","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13659-022-00363-y","article-title":"Natural products in cosmetics","volume":"12","author":"Liu","year":"2022","journal-title":"Natural Products and Bioprospecting"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0980","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1080\/14756366.2021.1960830","article-title":"Cyanobacteria and microalgae bioactive compounds in skin-ageing: potential to restore extracellular matrix filling and overcome hyperpigmentation","volume":"36","author":"Favas","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ics.12435","article-title":"The promise of marine molecules as cosmetic active ingredients","volume":"40","author":"Brunt","year":"2018","journal-title":"Int. J. Cosmet. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2023.115574_b0990","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1111\/jocd.15437","article-title":"Potential application of natural bioactive compounds as skin-whitening agents: A review","volume":"21","author":"Zhao","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115574_b0995","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/med.21506","article-title":"Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer","volume":"38","author":"Fathi","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b1000","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s13346-020-00743-2","article-title":"The solid progress of nanomedicine","volume":"10","author":"Martins","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"issue":"10","key":"10.1016\/j.bcp.2023.115574_b1005","doi-asserted-by":"crossref","first-page":"1603446","DOI":"10.1002\/smll.201603446","article-title":"Two-dimensional nanomaterials for cancer nanotheranostics","volume":"13","author":"Chen","year":"2017","journal-title":"Small"},{"issue":"36","key":"10.1016\/j.bcp.2023.115574_b1010","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1002\/smll.201600635","article-title":"Cancer-targeted nanotheranostics: recent advances and perspectives","volume":"12","author":"Ma","year":"2016","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b1015","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/med.21642","article-title":"Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer","volume":"40","author":"Liu","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b1020","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/21691401.2017.1373659","article-title":"Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis","volume":"46","author":"Shrotriya","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bcp.2023.115574_b1025","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.2147\/DDDT.S123759","article-title":"Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation","volume":"10","author":"Al-Amin","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b1030","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1080\/10717544.2021.1983081","article-title":"Targeting delivery and minimizing epidermal diffusion of tranexamic acid by hyaluronic acid-coated liposome nanogels for topical hyperpigmentation treatment","volume":"28","author":"Liu","year":"2021","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b1035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.22270\/jddt.v9i2.2453","article-title":"Potential benefits of phytochemicals for treatment of hyperpigmentation","volume":"9","author":"Kaur","year":"2019","journal-title":"Journal of Drug Delivery and Therapeutics"},{"issue":"3","key":"10.1016\/j.bcp.2023.115574_b1040","doi-asserted-by":"crossref","DOI":"10.1117\/1.JNP.13.036006","article-title":"Surface-enhanced Raman scattering of hydroquinone assisted by gold nanorods","volume":"13","author":"Cabrera-Alonso","year":"2019","journal-title":"J. Nanophotonics"},{"key":"10.1016\/j.bcp.2023.115574_b1045","unstructured":"A. Nautiyal, S. Wairkar, Management of Hyperpigmentation: Current Treatments and Emerging Therapies, Pigment Cell & Melanoma Research."},{"issue":"2","key":"10.1016\/j.bcp.2023.115574_b1050","doi-asserted-by":"crossref","first-page":"1603524","DOI":"10.1002\/adfm.201603524","article-title":"Advanced functional nanomaterials for theranostics","volume":"27","author":"Huang","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bcp.2023.115574_b1055","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.2147\/OTT.S140671","article-title":"Theranostics in nuclear medicine practice","volume":"10","author":"Yordanova","year":"2017","journal-title":"OncoTargets and therapy"},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b1060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/cr300213b","article-title":"Nanomaterials for theranostics: recent advances and future challenges","volume":"115","author":"Lim","year":"2015","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2023.115574_b1065","first-page":"2023","article-title":"Lipid based nanocarriers: a translational perspective, Nanomedicine: Nanotechnology","volume":"14","author":"Mishra","year":"2018","journal-title":"Biology, and Medicine"},{"key":"10.1016\/j.bcp.2023.115574_b1070","article-title":"Formulation, Optimization, and Evaluation of Ultradeformable Nanovesicles for Effective Topical Delivery of Hydroquinone","author":"Jamadar","year":"2022","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.bcp.2023.115574_b1075","first-page":"1","article-title":"Antioxidant and anti-tyrosinase activities of quercetin-loaded olive oil nanoemulsion as potential formulation for skin hyperpigmentation","author":"Silva","year":"2022","journal-title":"J. Dispers. Sci. Technol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115574_b1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104362","article-title":"Development of nanoformulation for hyperpigmentation disorders: Experimental evaluations, in vitro efficacy and in silico molecular docking studies","volume":"15","author":"Budama-Kilinc","year":"2022","journal-title":"Arab. J. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115574_b1085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/molecules28010220","article-title":"Decrypting the Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder","volume":"28","author":"Singh","year":"2023","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bcp.2023.115574_b1090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11051-022-05534-z","article-title":"Advances in cosmeceutical nanotechnology for hyperpigmentation treatment","volume":"24","author":"Tangau","year":"2022","journal-title":"J. Nanopart. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300165X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300165X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:54:48Z","timestamp":1736312088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522300165X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":218,"alternative-id":["S000629522300165X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115574","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115574"}}